{"article_link": "https://doi.org/10.1038/s41467-024-47463-6", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842", "format": "txt", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE228842"}, {"id": "data_6", "omics": "Proteomics", "link": "https://doi.org/10.1038/s41467-024-47463-6", "format": "txt", "source": "Supplementary Data File", "public_id": "Supplementary Data"}], "analyses": [{"id": "analysis_1", "analysis_name": "Differential analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_2", "analysis_name": "Gene set enrichment analysis (GSEA)", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_3", "analysis_name": "Principal Component Analysis (PCA)", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_6", "analysis_name": "Blood transcriptional module (BTM) analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_7", "analysis_name": "Differential analysis", "analysis_data": ["data_6"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_8", "analysis_name": "CIBERSORTx deconvolution", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_9", "analysis_name": "MicroRNA Target Enrichment Analysis (Integrated miRNA-mRNA)", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_10", "analysis_name": "Small RNA Differential Analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_11", "analysis_name": "3rd-Gen RNA-Seq Differential Analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_12", "analysis_name": "miRNA-Target Enrichment Analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_13", "analysis_name": "Blood Count Analysis", "analysis_data": ["data_6"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_14", "analysis_name": "Cytokine Profiling", "analysis_data": ["data_6"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}, {"id": "analysis_15", "analysis_name": "miRNA Differential Analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "timepoint": ["D0", "CT", "CT+7"]}}], "results": [{"analysis_id": "analysis_1", "metrics": "number_of_DEGs", "value": "684", "features": []}, {"analysis_id": "analysis_1", "metrics": "number_of_significant_DEGs", "value": "5", "features": []}, {"analysis_id": "analysis_1", "metrics": "fold_change", "value": "higher in placebo group", "features": ["MX1-201 isoform (ENST00000288383)"]}, {"analysis_id": "analysis_1", "metrics": "downregulation", "value": "yes", "features": ["KREMEN1 (SARS-CoV-2 receptor)"], "details": "KREMEN1 was downregulated in placebo vaccinated individuals compared with ChAdOx1 nCoV-19 recipients."}, {"analysis_id": "analysis_2", "metrics": "enrichment_p_value", "value": "0.01", "features": ["response to virus", "type I interferon"]}, {"analysis_id": "analysis_2", "metrics": "enrichment_p_value", "value": "0.01", "features": ["type I interferon", "complement activation"]}, {"analysis_id": "analysis_6", "metrics": "enrichment_p_value", "value": "0.01", "features": ["humoral immune response", "complement regulation"]}, {"analysis_id": "analysis_7", "metrics": "expression_level", "value": "higher in placebo group", "features": ["IP10", "IL10", "MCP1", "IL18", "TNF-alpha", "CXCL10"]}, {"analysis_id": "analysis_8", "metrics": "cell_abundance_difference", "value": "lower neutrophil abundance in placebo group", "features": ["neutrophils"]}, {"analysis_id": "analysis_9", "metrics": "enrichment_p_value", "value": "0.01", "features": ["response to TNF-alpha", "interferon-gamma-mediated signaling pathway"]}, {"analysis_id": "analysis_10", "metrics": "fold_change", "value": "higher in NAAT+ve placebo group", "features": ["MX1-201 isoform", "snoRNA-derived sRNAs"]}, {"analysis_id": "analysis_12", "metrics": "enrichment_p_value", "value": "0.01", "features": ["interferon signaling", "TNF-alpha response"]}, {"analysis_id": "analysis_13", "metrics": "mean_difference", "value": "lower neutrophil and leucocyte counts in placebo group", "features": ["neutrophils", "leucocytes", "platelets", "lymphocytes"]}, {"analysis_id": "analysis_14", "metrics": "expression_level", "value": "higher in placebo group", "features": ["IFN-γ", "IP10", "IL18", "TNF-α"]}, {"analysis_id": "analysis_15", "metrics": "fold_change", "value": "higher in NAAT+ve placebo group", "features": ["miRNA downregulation"]}]}